Henan Xintiandi Pharmaceutical Co was established in 2005 with a registered capital of 99 million yuan, the existing assets of 300 million yuan. and is mainly engaged in pharmaceutical intermediates, fine chemicals R & D, production and sales.
Our leading products Hydroxyphenylglycine L, L-hydroxyphenylglycine Deng salt of Science and Technology Department of Henan Province have been identified as high-tech products, the project was included in the first and second batch of high-tech industrialization projects Henan provincial government. Our company is the first domestic development and production of L and its derivatives Hydroxyphenylglycine manufacturers, products of the technical quality indicators have reached the international advanced level.
Middle East Region (e.g. UAE); Oceania; North America (USA, Canada); Africa; Central America (e.g. Mexico); East Asia (e.g. China, Japan, Korea); Europe - EU countries; Europe - non EU (e.g. UK, Russia, ex-CIS countries); South America (e.g. Brazil, Colombia); South Asia (e.g. India, Pakistan, Sri Lanka); South East Asia (e.g. Thailand, Philippines, Singapore)
Primary business activity
Categories affiliated with HENAN NEWLAND PHARMACEUTICAL CO.,LTD
Are you a supplier?
Here's what CPhI Online can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation